ClinicalTrials.gg
Not yet recruitingNCT06899698Updated Mar 28, 2025

INSPIRATORY MUSCLE TRAINER ON AUTONOMIC MODULATION AND PULMONARY FUNCTION

An interventional study of Inspiratory muscle training and Traditional Training in Hemiplegic Stroke, sponsored by Adly A Adam. Not yet recruiting at 1 site in Egypt. Open to male participants aged 55 Years to 65 Years. Per ClinicalTrials.gov, last updated 2025-03-28.

Sponsored by Adly A Adam · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Primary completion was expected by Jun 2025, 1 year 5 months ago, but the record still lists the study as not yet recruiting.
Phase
Not applicable
Study type
Interventional
Enrollment
60
Allocation
Randomized
Ages
55 Years to 65 Years
Sex
Male
01

Study summary

Stroke individuals with hemiplegia often display difficulties in mobility, cardiopulmonary function...etc. All stroke patients had restrictive pulmonary dysfunction. Therefore, respiratory training improves their respiratory capacity, and orthostatic stress mediated respiratory, cardiovascular and autonomic response. Respiratory muscle training interventions are efficient in terms of pulmonary functional parameters. In advanced line, this study will be conducted to evaluate inspiratory muscle trainer effect on autonomic modulation and pulmonary function in stroke patients.

Read the detailed description

The second trigger of death and the most frequent life-threatening neurological disease are now strokes. Stroke is the third main cause of the death \& disability in Egypt. According to world health organization; from the total world's population, nearly 18.6 had severe disability and 79.7 million had moderate long-term disability. Respiratory dysfunction is a common complication of stroke, with an incidence of over 60%. Despite the high prevalence of stroke-induced respiratory dysfunction, how disordered breathing influences recovery and cognitive outcomes after ischemic stroke is unknown.

Patients with hemiplegia exhibited diminished respiratory muscle strength and pulmonary function at a more severe motor dysfunction level. Impaired inspiratory muscle strength was associated with reduced balance ability and limitations in activities required for daily living.

in the same line this study will be conducted to find out the effect of inspiratory muscle trainer on autonomic modulation and pulmonary function in patients with stroke.

Sixty chronic hemiplegic patients who aged from 55:65 years old will be recruited, and randomly divided into 2 equal groups; study group will receive threshold inspiratory muscle trainer for 8 weeks (24 sessions) and their medications, and traditional training, where control group will receive their prescribed medications in addition to the same traditional training.

02

Conditions studied

  • Hemiplegic Stroke

Browse trials for

03

In context

Stroke

8,255 studies on the registry are indexed under Stroke; 2,056 are open to participants now.

This study's planned enrollment of 60 is above the median of 49 across 6,024 interventional studies indexed under Stroke.

Browse Stroke studies →

Lead sponsor

Adly A Adam is the lead sponsor of 12 studies on the registry; 6 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
55 Years to 65 Years
Sexes eligible
Male
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Chronic hemiplegic post stroke patients 'at least 6months'
  • Men.
  • Age ranged 55-65years old.
  • ranged from 29.9- 34.9 kg/m2
  • (MMSE) scores of 23-27 indicate mild cognitive impairment
  • Did not participate in any selective exercise program for the respiratory muscles before.
  • Participants suffering from orthostatic hypotension a systolic BP decline ≥20 mm Hg or a diastolic BP decline ≥10 mm Hg on position change from sitting to standing.

    • Smokers will be defined as those (who had smoked >400 cigarettes in their lifetime)

Exclusion criteria

Exclusion Criteria:

  • Unstable cardiovascular problems.
  • Asthmatic patient.
  • Implanted pacemaker
  • Patients with chest infection.
  • Patients with pleural diseases.
  • Primary valvular disease.
  • History of spontaneous pneumothorax.
  • peripheral vascular disease.
  • Severe anemia being unable to follow RMT instructions or complete the questionnaires of the study due to cognitive impairment .
  • Previous lung surgery.
  • Long-term oxygen treatment.
  • Patients with chronic renal failure.
  • Any patient enrolled in an anther research study for at least 30 days.
  • Facial affection
Terms in these criteria, in plain language(3)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

BMI (body mass index)

Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.

What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.

MMSE and MoCA

Short tests of memory and thinking, each scored out of 30. Lower scores suggest more difficulty; criteria give a range, either to include people with memory problems or to leave them out.

Clinically significant

Judged by the study doctor to matter for your health or for the study. It is a doctor’s decision, so ask the study team if you are unsure whether something counts.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Quadruple (Participant, Care provider, Investigator, Outcomes assessor)
Enrollment
60 participants (estimated)

Study arms

  • Experimental
    Study Group

    Thirty chronic hemiplegic patients with mild cognitive impairment, and suffering from orthostatic hypotension will receive inspiratory muscle training for 30 minutes per day for at least 3 days a week for 8 weeks, medications, and traditional training along 8 weeks.

    Other: Inspiratory muscle training · Other: Traditional Training

  • Other
    Control Group

    Thirty chronic hemiplegic patients with mild cognitive impairment, and suffering from orthostatic hypotension will receive their medications, and traditional training along 8 weeks.

    Other: Traditional Training

Interventions

  • OtherInspiratory muscle training

    Only participants in the Study group 'Thirty chronic hemiplegic patients with mild cognitive impairment, and suffering from orthostatic hypotension' will receive inspiratory muscle training using Respiratory muscle strength: Threshold Inspiratory muscle trainer (TIMT): Philips Respironics model (Tayland- B00J417PHM), for 30 minutes per day for at least 3 days a week for 8 weeks.

  • OtherTraditional Training

    Both the study and control group 'Sixty chronic hemiplegic patients with mild cognitive impairment, and suffering from orthostatic hypotension' will receive a. bobath technique 'passive mobilization associated with tactile and proprioceptive stimuli aims to inhibits spasticity'; b. Proprioceptive neuromuscular facilitation 'based on spiral and diagonal patterns of movements in line to achieve normal movements' c. Rood technique 'focuses on the developmental sequence of recovery (from basic to complex) and the use of sensory stimulation to facilitate movement and postural responses' d. Johnstone method 'includes positioning and splinting to inhibit abnormal patterns and controlling tone to restore central control' e. Functional electrical stimulation; f. Balance training, j. Pelvic, and gait training, h. Activities of daily living, and finally, g. Sensrimotor training 'Active and active-assistive range-of motion exercises, Graded activities Start with easy activities'.

06

What researchers measure

Primary outcomes

  1. Blood Pressure

    systolic, diastolic blood pressure and mean arterial blood pressure those will be measure using Mercury sphygmomanometer and stethoscope (China ,1600G004).

    Time frame: Pre-treatment, and Post-treatment of the 8-weeks of the study protocol (24 Sessions).

  2. Pulmonary Function test

    Pulmonary function test using Spirometry will be used to evaluate (Compact; Vitalograph; Buckingham, England) FVC, FEV1, FEV1 / FVC will be measured three times per each time of evaluation on a computerized spirometer

    Time frame: Pre-treatment, and Post-treatment of the 8-weeks of the study protocol (24 Sessions).

Secondary outcomes

  1. Functional capacity and orthostatic hypotension assessment

    Sit to stand test will be used for functional capacity assessment in addition to assessing the blood pressure from sitting to standing positions before and after treatment

    Time frame: Pre-treatment, and Post-treatment of the 8-weeks of the study protocol (24 Sessions).

  2. Cognitive function

    Cognitive function will be assessed using the Mini-Mental State Examination (MMSE) scores that is a tool that can be used to systematically and thoroughly assess mental status. It is an 11-question measure that tests five areas of cognitive function: orientation, registration, attention and calculation, recall, and language. The maximum score is 30. A score of 23 or lower is indicative of cognitive impairment. The MMSE takes only 5-10 minutes to administer and is therefore practical to use repeatedly and routinely.

    Time frame: Pre-treatment, and Post-treatment of the 8-weeks of the study protocol (24 Sessions).

07

Study locations

1 site
  • Physical Therapy Faculty
    Giza, Dokki 12612, Egypt
    • Zeinab Mohamed Helmy, Professor of Physical Thera[y/ · ContactInfo@pt.cu.edu.eg · +2035676103
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Mar 28, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06899698
Lead sponsor
Adly A Adam
Responsible party
Adly A Adam (Lecturer of Physical Therapy, Cairo University) — Sponsor-investigator
First posted
Mar 28, 2025
Start date
Apr 1, 2025 (estimated)
Primary completion
Jun 1, 2025 (estimated)
Completion
Dec 1, 2025 (estimated)
Last update
Mar 28, 2025

Study contacts

Sara Mohamed Ahmed, Bachalor
Contact
Info@pt.cu.edu.eg
+2035676103 ext. 103
Zeinab Mohamed Helmy, Professor of Physical Therapy
Contact
Info@pt.cu.edu.eg
+2035676103 ext. 103
Sara Mohamed Ahmed, Bachelor of Physical Therapy
principal investigator · Physical Therapy Faculty
Ebtesam Nabil Abdel Mohsen, Lecturer of Physical Therapy
study director · Physical Therapy Faculty
Ebtesam Mohamed Fahmy, Professor of Neurology
study director · faculty of medicine
Zeinab Mohamed Helmy, Professor of Physical Therapy
study chair · faculty of physical therapy

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Mar 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion